Saturday, October 31, 2026
RSS

Inside BCI

Brain-Computer Interface Industry News
Industry News Research Policy Opinion Market Moves
About Directory Glossary

Tag: Coherence-Neuro

3 articles

Market Moves

Founders Fund and the OpenAI Startup Fund co-lead Coherence Neuro's US$45 million round

Coherence Neuro, which is developing a brain implant to monitor and treat brain tumours, announced a US$45 million round, which it calls its Series A, on 21 October 2026, co-led by Founders Fund and the OpenAI Startup Fund. The money is for its first long-term human trial in glioblastoma, an application for FDA Breakthrough Device designation and preclinical work in pancreatic cancer. Chief executive Ben Woodington says OpenAI will not have access to any brain or health data the company generates.

Oct 22

Market Moves

The BCI category is broadening beyond motor restoration in 2026

Across the first half of 2026 and the first weeks of the second half, three US Food and Drug Administration Breakthrough Device Designations were granted to non-motor-indication BCI and neuromodulation devices, Cortigent's existing Breakthrough-designated visual cortical prosthesis programme disclosed a secondary stroke motor rehab arm, three first-in-human or investigational-device clinical milestones landed, and two significant peer-reviewed publications extended the field's clinical use case. The motor-restoration pipeline itself continued to expand in the same window. This is a synthesis piece on what the data pattern actually shows and does not show.

Jul 13